Clinical Trial Update: n-3 Fatty Acid Infusion and Type 2 Diabetes [NA]

View source ↗

Summary

This clinical trial update indicates the study of an n-3 fatty acid infusion in individuals with Type 2 diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• n-3 Fatty Acid Infusion

Snippet

Sponsor: St. Olavs Hospital | Conditions: Type 2 Diabetes | NA | Status: COMPLETED